InvestorsHub Logo
Followers 58
Posts 661
Boards Moderated 0
Alias Born 07/11/2017

Re: None

Friday, 09/15/2017 2:01:26 AM

Friday, September 15, 2017 2:01:26 AM

Post# of 18649
Looks like a technical bounce to $13 range is about to start. The company can't be compared to what it was before. It's now gotten competent management and new products in the pipeline. Debt is zero. Dilution will always happen to any biotech company. The key here is they aren't at risk for going BK tomorrow like before.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News